Loading...

'4/24/2026 11:49:08 AM'

Eugene Braunwald, Cardiology Pioneer, Dies at 96

Eugene Braunwald transformed cardiovascular medicine through seven decades of groundbreaking research, clinical trials, and mentorship that saved countless lives. Medscape Medical News

'4/24/2026 10:47:02 AM'

Fecal Microbiota From Younger Self Forestalls Aging in Mice

Preclinical research suggests altering the gut microbiome could someday hinder some signs of aging in people. Medscape Medical News

'4/24/2026 9:49:44 AM'

Late-Night Eating Combined With Stress ‘Double-Hit’ on Gut

The combination of high stress and consumption of about a quarter of the day’s food in late evening takes its toll in what experts call a ‘chrononutrition-stress axis.’ Medscape Medical News

'4/24/2026 9:25:56 AM'

Supporters Vow to Revive Assisted Dying Bill

The Terminally Ill Adults Bill fell without a Lords vote on Friday after procedural wrangling ended its 18-month journey through Parliament. Press Association

'4/24/2026 8:45:07 AM'

Use of GLP-1s in Type 1 Diabetes Not Linked to Increased DKA

In single-center study, GLP-1 use in people with type 1 diabetes was associated with lower hospitalization rates. Medscape Medical News

'4/24/2026 8:38:45 AM'

Home Training Boosts Fitness in Repaired Tetralogy of Fallot

High intensity interval training boosts exercise capacity in adolescents and young adults with repaired tetralogy of Fallot, without causing harmful changes in heart structure or function. Medscape Medical News

'4/24/2026 7:54:45 AM'

EMA Says No to Drug for PD-L1-High Melanoma

Although the agency did not recommend an extension of Opdualag’s indications, it did say new data could be added to its product information. Medscape News Europe

'4/24/2026 6:39:07 AM'

EMA Backs Drug for Rare Hypertriglyceridemia Disorder

Familial chylomicronemia syndrome is a rare inherited disease that prevents the body from breaking down lipids. Redemplo enhances liver uptake of lipoprotein remnants. Medscape News Europe

'4/24/2026 6:31:49 AM'

New NHS Standards Target Leading Causes of Maternal Death

New clinical standards from NHS England targeting blood clots, mental health, haemorrhage, and epilepsy aim to cut maternal deaths by March 2027. Medscape News UK

'4/24/2026 5:54:24 AM'

EMA Greenlights Drugs for MS and Spinal Muscular Atrophy

Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA. Medscape News Europe

'4/24/2026 5:38:11 AM'

EMA Recommends Generic in Advanced/Metastatic Breast Cancer

Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer. Medscape News Europe

'4/24/2026 4:51:57 AM'

ICIs Show High Responses in Mediastinal B-Cell Lymphoma

Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy. Medscape Medical News

'4/24/2026 4:49:31 AM'

HBP May Pose Major Risks for Young Veterans Post-9/11

A new trend emerging in post-9/11 veterans shows that roughly half of this young adult group has hypertension, and more than half of those cases go undetected. Medscape Medical News

'4/24/2026 4:33:55 AM'

Pediatric Offices Urged to Drill for Emergencies

Naloxone is added to the list of essential medications, whereas psychiatric crises are included for the first time. Medscape Medical News

'4/24/2026 4:31:38 AM'

Pancreatic Cancer Vaccine Still Shows Promise 6 Years Out

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types. Medscape Medical News

'4/24/2026 4:13:58 AM'

Lilly's Obesity Pill Hits Nearly 4000 Prescriptions in Second Week After Launch

Eli Lilly's newly launched oral weight loss drug was prescribed 3,707 times in the U.S. ⁠in the second week after its launch earlier this month, according to analysts... Reuters Health Information

'4/24/2026 4:12:29 AM'

First Positive Phase 3 Drug Trial for MOGAD

Satralizumab is safe and effective for patients with myelin oligodendrocyte glycoprotein antibody-associated disease, the new phase 3 METEOROID trial shows. Medscape Medical News

'4/24/2026 4:00:00 AM'

Naltrexone Alters Affective Intensity of Threat in the Brain

Opioid antagonism with naltrexone alters neural responses to threatening stimuli and reduces subjective distress, supporting a role for opioids in automatic emotional regulation. Medscape News UK

'4/24/2026 4:00:00 AM'

Sex Affects Outcomes in Severe Tricuspid Regurgitation

Women with severe tricuspid regurgitation exhibit fewer comorbidities, less right ventricular remodelling, and significantly better long-term survival rates than men. Medscape News UK

'4/24/2026 4:00:00 AM'

Suboptimal UDCA Dosing Found in Primary Biliary Cholangitis

Nearly all patients with primary biliary cholangitis receive ursodeoxycholic acid, but a substantial proportion are prescribed suboptimal doses, a new Dutch study shows. Medscape News UK